vimarsana.com
Home
Live Updates
Alterity Therapeutics to Present New Data at the Upcoming Am
Alterity Therapeutics to Present New Data at the Upcoming Am
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to be Presented from Ongoing ATH434-201...
Related Keywords
Colorado ,
United States ,
San Francisco ,
California ,
Denver ,
Australia ,
Melbourne ,
Victoria ,
American ,
Americans ,
David Stamler ,
Margaret Bradbury ,
Danielo Claassen ,
Daniel Claassen ,
Remy Bernarda ,
Hannah Howlett ,
Parkinson Foundation ,
European Commission ,
Nonclinical Development ,
Nasdaq ,
Securities Exchange ,
System Atrophy National Institute Of Neurological Disorders ,
Vanderbilt University Medical Center ,
International Conference ,
Alterity Therapeutics ,
National Institute Of Health ,
American Academy Of Neurology ,
Vanderbilt University ,
Positive Efficacy Data ,
Primate Model ,
Baseline Biomarker Data ,
American Academy ,
Chief Executive Officer ,
Novel Inhibitor ,
Synuclein Aggregation ,
Multiple System Atrophy ,
Plight Chain ,
Clinical Progression ,
Early Multiple System ,
Vanderbilt University Medical ,
Clinical Phase Small Molecule ,
Moderate Affinity ,
Disease Model ,
Vice President ,
System Atrophy ,
National Institute ,
Neurological Disorders ,
Disease Information Page ,
Multiple System ,
Media Contacts ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Markets ,